Key result
Thrombasthenic blood exhibits increased platelet contact, indicating glycoprotein IIb-IIIa mediates platelet spreading on subendothelium.
Population
Blood from patients with thrombasthenia exposed to rabbit aorta subendothelium in an annular chamber
Design
Preclinical
Follow-up
Up to 10 minutes (exposure times of 1, 2, 3, 5, and 10 min)
Authors
Loading...
Ex vivo data implicate glycoprotein IIb-IIIa in platelet spreading; leaves open whether this informs antiplatelet strategies in humans.
Observational
The study provides conclusive ex vivo evidence that glycoprotein IIb-IIIa mediates platelet spreading on the subendothelium.
Weiss et al. (1991) conducted an observational in Thrombasthenia. Thrombasthenia (GPIIb-IIIa defect) was evaluated on Percent surface coverage of the vessel segment with platelets in the contact (C) and spread (S) stage. Blood from patients with thrombasthenia exhibited increased platelet contact at all exposure times, providing evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: